GIL INVESTOR ALERT: Gildan Activewear Inc. Investors with Substantial Losses
Gildan Activewear Inc. (NYSE: GIL) is facing multiple securities class action lawsuits alleging the apparel manufacturer engaged in channel stuffing and misled investors about its financial performance. Several law firms, including Robbins Geller Rudman & Dowd LLP, Rosen Law Firm, Kahn Swick & Foti LLC, and Robbins LLP, have filed competing actions on behalf of investors who purchased or acquired Gildan publicly traded securities between February 19, 2025 and June 15, 2026.
Allegations by Jehoshaphat Research
The lawsuits stem from allegations by Jehoshaphat Research, a U.S.-based activist short seller with a history of targeting Canadian companies. On June 16, 2026, Jehoshaphat published a report claiming Gildan had been pushing excess product into distribution channels beyond underlying consumer demand to artificially inflate revenue figures.
Channel stuffing is the practice of pushing more product into distribution channels than necessary for actual demand, often using extended payment terms and incentives to inflate short-term revenue growth by pulling forward future sales. Jehoshaphat alleged that Gildan incentivized distributors and customers to take on more product than demand could absorb by offering extended payment terms of 90-120 days at quarter-ends.
The short seller estimated that Gildan's distributors and customers held approximately $510 million in excess inventory as of the first quarter of 2026. The report also alleged that the company's days sales outstanding had reached about 129 days in the first quarter of 2026, more than double the historical average of 57 days from 2000-2022. Jehoshaphat disclosed it held a short position representing approximately 4% of Gildan's public float and based its allegations on interviews with former Gildan employees and customers, as well as accounting analysis.
Market Impact and Company Response
Following publication of the Jehoshaphat report, Gildan's NYSE-listed shares declined nearly 19%. An article published by Investing.com on June 16, 2026 summarized the short seller's findings, noting the alleged product overhang contrasted sharply with consensus forecasts for 2026.
Gildan issued a statement the same day reiterating its fiscal 2026 guidance and expressing confidence that its current disclosure provides investors with accurate and comprehensive information. The company stood by its financial reporting and governance practices in response to the allegations.
Legal Proceedings
The lawsuits, filed in the United States District Court for the Northern District of New York under case number 26-cv-02126, allege that Gildan and certain current and former executives violated the Securities Exchange Act of 1934. The complaints assert that defendants made false and misleading statements throughout the class period by failing to disclose that Gildan lacked adequate internal controls, used channel stuffing to create an appearance of revenue, and made materially false statements about the company's business, operations, and prospects.
Distribution Network Concentration
The context of Gildan's concentrated distribution network adds significance to the allegations. According to the Jehoshaphat report, close to half of Gildan's sales flow through three distributors, with the single largest distributor—S&S, which acquired alphabroder in 2024—accounting for roughly a third of net sales in 2025. This concentration could amplify the impact of alleged channel stuffing practices.
Previous Litigation History
This is not the first time Gildan has faced securities litigation. The company previously settled U.S. and Canadian class action lawsuits in 2010 for $22.5 million, which was entirely funded by the company's insurers. Those 2008 lawsuits related to financial guidance revisions and were consolidated in the U.S. District Court for the Southern District of New York, with final court approvals obtained in February and March 2011.
Lead Plaintiff Appointment Process
Under the Private Securities Litigation Reform Act of 1995, investors who purchased Gildan securities during the class period may seek appointment as lead plaintiff. The law presumes that the plaintiff with the largest financial interest in the relief sought is the most adequate lead plaintiff, and limits individuals to serving as lead plaintiff in no more than five securities class actions during any three-year period. All competing law firms have set December 14, 2026 as the deadline for investors to file motions for lead plaintiff appointment.
A lead plaintiff acts on behalf of all class members in directing the litigation and can select a law firm of their choice to litigate the case. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Robbins Geller Rudman & Dowd LLP, one of the firms pursuing the case, ranked first on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. The firm has obtained some of the largest securities class action recoveries in history, including a $7.2 billion recovery in the Enron securities litigation.
